What Is Retatrutide? Retatrutide is a next-generation investigational peptide developed for the management of obesity, metabolic dysfunction, and Type 2 diabetes. Unlike traditional diabetes medications that target a single hormone pathway, Retatrutide is a triple hormone receptor agonist that activates: ✔ GLP-1 (Glucagon-Like Peptide-1) ✔ GIP (Glucose-Dependent Insulinotropic Polypeptide) ✔ Glucagon Receptors This unique triple-action